Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The ability to discriminate between Alzheimer’s disease (AD), subcortical vascular disease, and other cognitive disorders is crucial for diagnostic purposes and clinical trial outcomes. Patients with primarily subcortical vascular disease are unlikely to benefit from treatments targeting the AD pathogenic mechanisms and vice versa. The Gothenburg mild cognitive impairment (MCI) and dementia studies are prospective, observational, single-center cohort studies suitable for both cross-sectional and longitudinal analysis that outline the cognitive profiles and biomarker characteristics of patients with AD, subcortical vascular disease, and other cognitive disorders. The studies, the first of which started in 1987, comprise inpatients with manifest dementia and patients seeking care for cognitive disorders at an outpatient memory clinic. This article gives an overview of the major published papers (neuropsychological, imaging/physiology, and neurochemical) of the studies including the ongoing Gothenburg MCI study. The main findings suggest that subcortical vascular disease with or without dementia exhibit a characteristic neuropsychological pattern of mental slowness and executive dysfunction and neurochemical deviations typical of white matter changes and disturbed blood–brain barrier function. Our findings may contribute to better healthcare for this underrecognized group of patients. The Gothenburg MCI study has also published papers on multimodal prediction of dementia, and cognitive reserve.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700 · cited 1×
“Incipient and manifest AD are characterized by increased CSF levels of phosphorylated tau (P-tau) linked to formation of neurofibrillary tangles, and ‘total’ tau (T-tau) mirroring axonal degeneration together with decreased levels of A 1-42 reflecting the amount of amyloid plaques.(8,9) Most studies have compared AD p…”
BackgroundSelf-citation(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291 · cited 1×
“Incipient and manifest AD are characterized by increased CSF levels of phosphorylated tau (P-tau) linked to formation of neurofibrillary tangles, and ‘total’ tau (T-tau) mirroring axonal degeneration together with decreased levels of A 1-42 reflecting the amount of amyloid plaques.(8,9) Most studies have compared AD p…”
BackgroundSelf-citationCSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176
Subcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
Self-citationYoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829 · cited 1×
“In one prevalence study, it was found to constitute as much as 50% of cases with vascular dementia.(10) In its pronounced pure form, subcortical vascular disease gives rise to a characteristic phenotype with predominant speed/attention and executive impairments called subcortical (ischemic) vascular dementia (SVD).”
BackgroundShi, F., Liu, B., Zhou, Y., Yu, C., & Jiang, T. (2009) · Hippocampus · doi:10.1002/hipo.20573 · Cited by 470
Gouw, A. A., van der Flier, W. M., Fazekas, F., van Straaten, E. C. W., Pantoni, L., Poggesi, A., Inzitari, D., Erkinjuntti, T., Wahlund, L. O., Waldemar, G., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.498535 · Cited by 384
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360
Self-citation
Cited by
Skrobot, O. A., Black, S. E., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., O'Brien, J., Pantoni, L., Pasquier, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.007 · Cited by 431
“The use of biomarkers and advances in imaging criteria [38,45,46], including the use of arterial spin–labeling MRI [47,48], may refine the subtyping of mild and major VCI.”
Self-citationThe Vascular Impairment of Cognition Classification Consensus Study
Skrobot, O. A., O'Brien, J., Black, S., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., Pantoni, L., Pasquier, F., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.10.007 · Cited by 242
Self-citationThe EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Bos, I., Vos, S., Vandenberghe, R., Scheltens, P., Engelborghs, S., Frisoni, G., Molinuevo, J. L., Wallin, A., Lleó, A., Popp, J., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0396-5 · Cited by 112
Self-citationCognitive medicine – a new approach in health care science.
Wallin, A., Kettunen, P., Johansson, P. M., Jonsdottir, I. H., Nilsson, C., Nilsson, M., Eckerström, M., Nordlund, A., Nyberg, L., Sunnerhagen, K. S., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1615-0 · Cited by 27
“In contrast, subcortical small vessel disease displays a cognitive pattern of early dysfunction of mental speed and executive capacity [14, 15].”
Background
Metadata
- Authors
- Wallin, A., Nordlund, A., Jonsson, M., Blennow, K., Zetterberg, H., Öhrfelt, A., Stålhammar, J., Eckerström, M., Carlsson, M., Olsson, E., Göthlin, M., Svensson, J., Rolstad, S., Eckerström, C., & Bjerke, M.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2015-07-29
- Volume
- 36
- Issue
- 1
- Pages
- 95-113
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2259127926
- Cited by
- 48
- References
- 20
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies. https://app.cochat.ai/papers/10.1038/jcbfm.2015.148
- The paper
- Wallin, A., Nordlund, A., Jonsson, M., Blennow, K., Zetterberg, H., Öhrfelt, A., Stålhammar, J., Eckerström, M., Carlsson, M., Olsson, E., Göthlin, M., Svensson, J., Rolstad, S., Eckerström, C., & Bjerke, M. (2016). Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1038/jcbfm.2015.148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.